Many people with Lewy body dementia (LBD) and Alzheimer’s disease have similar symptoms, especially in the early stages. This can make it hard for doctors to know exactly what is causing a person’s memory, thinking or movement problems.
The Clin-Syn study aims to learn more about biological changes in the body to help doctors better identify and understand these diseases, particularly in the early stages. This is important to help guide diagnosis and care, including developing new treatments for these diseases.
Read More
Researchers are studying medications that are FDA-approved for other conditions or have demonstrated safety in previous clinical use. These studies are designed to determine whether these treatments may also help reduce agitation symptoms and improve overall well-being in individuals with Alzheimer’s disease.
Read More
Researchers are studying medications that are FDA-approved for other conditions or have demonstrated safety in previous clinical use. These studies are designed to determine whether these treatments may also help reduce psychosis symptoms and improve overall well-being in individuals with Alzheimer’s.
Read More
Families with multiple members diagnosed with Alzheimer’s disease or related dementias are invited to join a national study focused on understanding the genetic risks associated with these conditions. Participation will provide invaluable insights that could significantly advance this crucial research.
Read More
Although nearly all people with Down syndrome have high levels of this brain pathology similar to Alzheimer’s, and their associated brain changes appear by the early age of 40, this population continues to be underserved when it comes to Alzheimer’s research.
Read More